Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
AKBA | US
Overview
Corporate Details
- ISIN(s):
- US00972D1054
- LEI:
- Country:
- United States of America
- Address:
- 245 FIRST STREET, 2142 CAMBRIDGE
- Website:
- https://akebia.com/
- Sector:
- Manufacturing
Description
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company that develops and commercializes therapeutics for patients with kidney disease. The company's mission is to improve the lives of people impacted by renal conditions by developing novel treatments that have the potential to set new standards of care. Akebia has two FDA-approved products, including Vafseo, an oral treatment for anemia in adult patients on dialysis. Its capabilities range from research and clinical development through to commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Akebia Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Akebia Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Akebia Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
